Svahn, B-M <br/><br/>
Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial.  [electronic resource] 

 -  Presse medicale (Paris, France : 1983)  Apr 2004 
 - 474-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0755-4982 
<br/><br/><label>Standard No.: </label>10.1016/s0755-4982(04)98635-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Ambulatory Care--statistics & numerical data<br/>Antineoplastic Agents--adverse effects<br/>Bone Marrow Purging--adverse effects<br/>Cross Infection--epidemiology<br/>Female<br/>Fever of Unknown Origin--epidemiology<br/>Follow-Up Studies<br/>Hematologic Neoplasms--drug therapy<br/>Home Care Services, Hospital-Based--statistics & numerical data<br/>Humans<br/>Length of Stay--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Opportunistic Infections--epidemiology<br/>Outcome and Process Assessment, Health Care--statistics & numerical data<br/>Pancytopenia--chemically induced<br/>Patient Isolation--statistics & numerical data<br/>Patient Readmission--statistics & numerical data<br/>Pilot Projects<br/>Risk Factors<br/>Stem Cell Transplantation<br/>Switzerland